Skip to main content
OpenTrials

Clinical trial condition

Virus Diseases

Explore clinical trials studying Virus Diseases. Study availability and eligibility vary by location and protocol.

514 public trials 52 recruiting studies
Refine in advanced search Browse all conditions

Virus Diseases trial results

Active, Not Recruiting

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.

NCT05683457

Conditions
Cytomegalovirus Infection, Cytomegalovirus Infections, DNA Virus Infections, +8 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT, SPIKEVAX X Injection, SPIKEVAX JN Injection and SPIKEVAX IN PRE-FILLED SYRINGE

NCT06333704

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Yonseimin Clinic Wŏnju, Gangwon-do, South Korea
  • Hyundai Clinic Bucheon-si, Gyeonggi-do, South Korea
  • Ma Hak ki Family Medicine Clinic Bucheon-si, Gyeonggi-do, South Korea
  • Nalee Hospital Gimpo-si, Gyeonggi-do, South Korea
View all 26 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above

NCT07204964

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Guntersville, Alabama, United States
  • GSK Investigational Site Canoga Park, California, United States
  • GSK Investigational Site Walnut Creek, California, United States
  • GSK Investigational Site Hialeah, Florida, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19

NCT07222384

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Stanford University Medical Center CTRU - 800 Welch Road Palo Alto, California, United States
  • California Research Foundation San Diego, California, United States
  • Indago Research & Health Center, Inc Hialeah, Florida, United States
  • C & R Research USA Homestead, Florida, United States
View all 29 locations
View Trial Details

Related conditions